Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy

被引:24
|
作者
Abrahamson, Martin J. [1 ]
Peters, Anne [2 ]
机构
[1] Harvard Univ, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
[2] Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA
关键词
Basal-bolus; insulin; intensification; type 2 diabetes mellitus; RAPID-ACTING INSULIN; TO-TARGET TRIAL; QUALITY-OF-LIFE; CONSENSUS STATEMENT; GLYCEMIC CONTROL; EUROPEAN-ASSOCIATION; MEDICAL-MANAGEMENT; INITIATING INSULIN; MEALTIME TREATMENT; ORAL-AGENTS;
D O I
10.3109/07853890.2012.699715
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of diabetes mellitus is projected to continue to increase worldwide over the next 20 years leading to increased costs in the management of the disease and its associated co-morbidities. Insulin replacement is one of many treatment options that can help to bring about near normoglycemia in the patient with type 2 diabetes mellitus (T2DM). Glycemic control as close to normoglycemia as possible can help to reduce the risk of microvascular and macrovascular complications, yet less than one-half of patients with T2DM achieve glycemic targets as recommended by practice guidelines. The purpose of this review is to provide guidance to primary care physicians for the initiation and intensification of basal-bolus insulin therapy in patients with T2DM. Two treatment algorithms that can be both patient- and physician-driven are proposed: a stepwise approach and a multiple daily injections approach. Evidence shaping the two approaches will be discussed alongside management issues that surround the patient treated with insulin: hypoglycemia, weight gain, patient education, and quality of life.
引用
收藏
页码:836 / 846
页数:11
相关论文
共 50 条
  • [1] Stepwise intensification of prandial insulin versus basal-bolus insulin therapy in patients with type 2 diabetes mellitus
    Raccah, D.
    Haak, T.
    Huet, D.
    Monnier, L.
    Ramon, J. S.
    Robertson, D.
    Labard, P.
    Penfornis, A.
    [J]. DIABETOLOGIA, 2010, 53
  • [2] Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?
    Giugliano, D.
    Sieradzki, J.
    Stefanski, A.
    Gentilella, R.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1425 - 1434
  • [3] Stepwise Intensification of Prandial Insulin Versus Basal-Bolus Insulin Therapy in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Raccah, Denis
    Haak, Thomas
    Huet, Dominique
    Monnier, Louis
    Penfornis, Alfred
    Robertson, Douglas
    Labard, Pascale
    Soler Ramon, Juan
    [J]. DIABETES, 2010, 59 : A151 - A151
  • [4] Basal-bolus insulin therapy and glycemic control in adult patients with type 2 diabetes mellitus: A review of the literature
    Jackson, Bridget
    Grubbs, Laurie
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2014, 26 (06) : 348 - 352
  • [5] Insulin Degludec: Reduction of Hypoglycemia during Basal-Bolus Therapy in Patients with Diabetes Mellitus Type 1 or 2
    Luedemann, J.
    Merker, L.
    Milek, K.
    Kaiser, M.
    Wilhelm, B.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2013, 8 (01) : 35 - 42
  • [6] OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
    Galkina, G. A.
    Voropay, A. A.
    Levkovich, M. A.
    Vorobiov, S. V.
    Komkova, M. V.
    Morozova, N. V.
    [J]. BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 15 - U223
  • [7] ALGORITHM-DRIVEN BASAL-BOLUS THERAPY IN HOSPITALIZED PATIENTS WITH TYPE 2 DIABETES: IMPLICATIONS FOR DISCHARGE THERAPY
    Hochfellner, D.
    Baumann, P.
    Beck, P.
    Mader, J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A28 - A28
  • [8] Proportion and characteristics of patients with type 2 diabetes initiating basal insulin therapy with a basal-bolus regimen in China
    Zhang, Puhong
    Zhang, Heng
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Lu, Juming
    Jia, Weiping
    Ji, Linong
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [9] THE COSTS OF INTENSIFICATION FROM BASAL INSULIN TO BASAL-BOLUS IN TYPE 2 DIABETES: A SURVEY OF PHYSICIANS
    Pfeiffer, K. M.
    Basse, A.
    Brod, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S74 - S74
  • [10] HOW HYPOGLYCEMIA IMPACTS QUALITY OF LIFE AND TREATMENT SATISFACTION IN TYPE 2 DIABETES MELLITUS PATIENTS ON BASAL-BOLUS INSULIN THERAPY?
    Ionova, T. I.
    Odin, V., I
    Nikitina, T. P.
    Kurbatova, K. A.
    Shablovskaya, N. E.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A446 - A446